Open for inclusion

Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy

Cancer type: Solide tumores

Phase: I

Principal Investigator: Geertsen Poul

Country: DK

Keywords: Denmark, Herlev, M3814, solid tumors

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02516813?term=02516813&rank=1